Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-06-05

Clinical Trial Update: A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart [Phase 4]

View source ↗

Summary

This Phase 4 trial investigates whether switching from finasteride (Proscar) to dutasteride (Avodart) improves symptoms of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avodart (dutasteride)
  • PROSCAR (FINASTERIDE)

Snippet

Sponsor: Urologic Consultants of Southeastern PA | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: UNKNOWN